The Role of IL-10 in Gastric Spasmolytic Polypeptide-Expressing Metaplasia-Related Carcinogenesis

참고문헌 (10)

1. Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2012)
2. Tan P, "Genetics and molecular pathogenesis of gastric adenocarcinoma", Gastroenterology, 149, pp.1153~1162.e3 (2015)
3. Asada K, "Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study", Gut, 64, pp.388~396 (2015)
4. Weis VG, "Current understanding of SPEM and its standing in the preneoplastic process", Gastric Cancer, 12, pp.189~197 (2009)
5. Cardoso CM, "Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency", Toxicol Appl Pharmacol, 176, pp.145~152 (2001)
6. Huh WJ, "Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach", Gastroenterology, 142, pp.21~24.e7 (2012)
7. Goldenring JR, "Reversible drug-induced oxyntic atrophy in rats", Gastroenterology, 118, pp.1080~1093 (2000)
8. 이찬수, "IL-10 Plays a Pivotal Role in Tamoxifen-Induced Spasmolytic Polypeptide-Expressing Metaplasia in Gastric Mucosa", Gut and Liver, 11(6), pp.789~797 (2017), 거트앤리버 발행위원회
9. Neven B, "A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency", Blood, 122, pp.3713~3722 (2013)
10. Fujii S, "Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ", Blood, 98, pp.2143~2151 (2001)

관련 논문AI추천